Minimal invasive treatments for liver malignancies

Research output: Contribution to journalArticlepeer-review


Minimal invasive therapies have proved useful in the management of primary and secondary hepatic malignancies. The most relevant aspects of all these therapies are their minimal toxicity profiles and highly effective tumor responses without affecting the normal hepatic parenchyma. These unique characteristics coupled with their minimally invasive nature provide an attractive therapeutic option for patients who previously may have had few alternatives. Combination of these therapies might extend indications to bring curative treatment to a wider selected population. The results of various ongoing combination trials of intraarterial therapies with targeted therapies are awaited to further improve survival in this patient group. This review focuses on the application of ablative and intra-arterial therapies in the management of hepatocellular carcinoma and hepatic colorectal metastasis.

Original languageEnglish
Pages (from-to)659-667
Number of pages9
JournalUltrasonics Sonochemistry
Publication statusPublished - Apr 30 2015


  • Ablative therapies
  • Hepatic colorectal metastasis
  • HIFU
  • Liver malignancy
  • Minimally invasive treatment

ASJC Scopus subject areas

  • Chemical Engineering (miscellaneous)
  • Acoustics and Ultrasonics
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Minimal invasive treatments for liver malignancies'. Together they form a unique fingerprint.

Cite this